4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-058703
Chief Financial Officer sold 50,000 shares at an average $7.49 ($374,638)
- Chief Financial Officer acquired 75,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Secora Michael · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 968,514 | D |
| 2023-12-12 | Sale : show line 2 in the form 10b5-1 | −25,000 | $7.39 | $184,868 | 943,514 | D |
| 2023-12-13 | Exercise or conversion : show line 3 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 981,014 | D |
| 2023-12-13 | Sale : show line 4 in the form 10b5-1 | −25,000 | $7.59 | $189,770 | 956,014 | D |
| Open-market sales · 50,000 sh · avg $7.49 · $374,638 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-12-12 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 1,147,635 | D |
| 2023-12-13 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 1,110,135 | D |
Loading xslF345X05/doc4.xml…